PAPER Milton NG

Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase.

Neuroreport. 2001 Dec 4;12(17):3839-44. PubMed.

PAPER Poduslo SE, Yin X

A new locus on chromosome 19 linked with late-onset Alzheimer's disease.

Neuroreport. 2001 Dec 4;12(17):3759-61. PubMed.

PAPER Moghadasian MH, McManus BM, Nguyen LB, Shefer S, Nadji M, Godin DV, Green TJ, Hill J, Yang Y, Scudamore CH, Frohlich JJ

Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans.

FASEB J. 2001 Dec;15(14):2623-30. PubMed.

PAPER Hama E, Shirotani K, Masumoto H, Sekine-Aizawa Y, Aizawa H, Saido TC

Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons.

J Biochem. 2001 Dec;130(6):721-6. PubMed.

PAPER Foy MR

17beta-estradiol: effect on CA1 hippocampal synaptic plasticity.

Neurobiol Learn Mem. 2001 Nov;76(3):239-52. PubMed.

PAPER Noble JM

Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.

BMJ. 2001 Nov 10;323(7321):1128. PubMed.

PAPER Warner J, Butler R

Drugs for Alzheimer's disease. More effective agents are needed.

BMJ. 2001 Nov 10;323(7321):1127-8. PubMed.

PAPER Meguro K, Shimada M, Someya K, Horikawa A, Yamadori A

Hemispatial visual-searching impairment correlated with decreased contralateral parietal blood flow in Alzheimer disease.

Neuropsychiatry Neuropsychol Behav Neurol. 2001 Oct-Dec;14(4):213-8. PubMed.

PAPER Koistinaho M, Ort M, Cimadevilla JM, Vondrous R, Cordell B, Koistinaho J, Bures J, Higgins LS

Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14675-80. PubMed.

PAPER Pearson VE

Galantamine: a new alzheimer drug with a past life.

Ann Pharmacother. 2001 Nov;35(11):1406-13. PubMed.

PAPER Pohjasvaara T, Ylikoski R, Leskelä M, Kalska H, Hietanen M, Kaste M, Erkinjuntti T

Evaluation of various methods of assessing symptoms of cognitive impairment and dementia.

Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):184-93. PubMed.

PAPER Doraiswamy PM, Kaiser L, Bieber F, Garman RL

The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.

Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):174-83. PubMed.

PAPER Hebert LE, Beckett LA, Scherr PA, Evans DA

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):169-73. PubMed.

PAPER Lleó A, Blesa R, Gendre J, Castellví M, Pastor P, Queralt R, Oliva R

A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer's disease.

Neurology. 2001 Nov 27;57(10):1926-8. PubMed.

PAPER Goldstein FC, Ashley AV, Gearing M, Hanfelt J, Penix L, Freedman LJ, Levey AI

Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.

Neurology. 2001 Nov 27;57(10):1923-5. PubMed.